Hematological Malignancies

EORTC/GELA/IIL H10 Study For early favorable and unfavorable HL H10 (#20051): study design

H10F

2 ABVD

PET

1 ABVD+INRT 30 Gy (+6)

R

P E T

- +

2 ABVD 2 BEACOPPesc+INRT 30(+6)

2 ABVD

*

H10U

2 ABVD

PET

2 ABVD+INRT 30 Gy (+6)

R

P E T

- +

4 ABVD 2 BEACOPPesc+INRT 30(+6)

2 ABVD

*

Hodgkin - CS I/II – untreated - 15-70 yrs – supradiaphragmatic - no NLPHL *PET-/+ according to protocol criteria